Is McKesson Stock Underperforming the Dow?

Irving, Texas-based McKesson Corporation (MCK) distributes pharmaceuticals, medical-surgical supplies, and health and beauty care products. With a market cap of $88.3 billion, the company also develops, implements, and supports software that facilitates the integration of data throughout the health enterprise. In addition, McKesson offers analytic, care management, and patient solutions for payers.

Companies worth $10 billion or more are generally described as “large-cap stocks.” MCK effortlessly fits that bill, with its market cap exceeding this mark, underscoring its size, influence, and dominance within the medical distribution industry. MCK stands as one of the titans in the U.S. pharmaceutical distribution landscape with an expansive distribution network and comprehensive product offerings enabling it to meet diverse customer needs effectively. MCK's ability to offer a wide range of services, from drug distribution to medical-surgical supply and technology solutions, allows it to tap into various revenue streams and mitigate risks associated with any single line of business.